Yellow Fever Clinical Trials

43 clinical trials for Yellow Fever across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated Participants — RECRUITING · NA
• Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective — RECRUITING
• Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination — RECRUITING · PHASE1
• Discovery of antigen and antibody profiles in response to yellow fever vaccination as a model for an infection — OTHER
• Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia — ACTIVE_NOT_RECRUITING · PHASE2
• A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults — COMPLETED · PHASE1
• A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers — COMPLETED · PHASE1
• Phase 3 Single Arm, Open Study on vYF in Adults — COMPLETED · PHASE3
• The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination — COMPLETED · PHASE1
• Human Immune Responses to Yellow Fever Vaccination — COMPLETED · PHASE4
• Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults — COMPLETED · PHASE1
• Trial of an Inactivated Yellow Fever Virus Vaccine — COMPLETED · PHASE1
• A randomized controlled trial to compare the immunogenicity and skin imprinting of intradermal, subcutaneous and intramuscular yellow fever vaccination — TERMINATED · PHASE3
• Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA — ACTIVE_NOT_RECRUITING · PHASE2
• A Pilot Study to Finetune Skin Processing Procedures in Recent Vaccinees, Prior to GeKoSkimm Study Initiation (GeKoSkimm-pilot) — COMPLETED · NA
• A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL — COMPLETED · PHASE3
• Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine — COMPLETED · PHASE4
• Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old — COMPLETED · PHASE4
• Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months — NOT_YET_RECRUITING · PHASE3
• Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina — ACTIVE_NOT_RECRUITING · NA
• Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination — OTHER · NA
• Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection — COMPLETED · PHASE2
• Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine — COMPLETED · PHASE4
• A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants — OTHER · PHASE3
• Yellow Fever Human Infection Model With YF-17D — OTHER · NA
• An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity — OTHER · PHASE2
• Booster Vaccine for Yellow Fever — OTHER · PHASE3
• Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers — COMPLETED · PHASE3
• Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine — COMPLETED · PHASE2
• Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) — COMPLETED · PHASE4
• A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19 — TERMINATED · PHASE1
• Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC — OTHER
• Evaluation of an Infant Immunization Encouragement Program in Nigeria — COMPLETED · NA
• Yellow Fever Vaccine on Statin/ Non Statin Subjects — COMPLETED · PHASE2
• Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea — COMPLETED
• The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. — COMPLETED · PHASE3
• Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in Children — OTHER
• Trial of Yellow Fever Inactivated Vaccine — COMPLETED · PHASE1
• The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans — COMPLETED · PHASE2
• Immunity After Two Doses of Yellow Fever Vaccine — COMPLETED
• A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults — COMPLETED · PHASE3
• Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) — COMPLETED · PHASE2
• Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy Adults — COMPLETED

Refine this search